CD8A and neoplasm: Moreover, Wang et al. demonstrated that RSL3 and erastin treatment did not affect the survival of naïve and shortly stimulated T cells, whereas immunotherapy-activated CD8+ T cells induced ferroptosis in tumor cells [18].